Cas 503170-91-0,tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2,3-dimethyl-4-quinolinyl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate

503170-91-0

Post Buying Request

Basic information

Product Name: tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2,3-dimethyl-4-quinolinyl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate
Synonyms:
CAS NO:503170-91-0
Molecular Formula:
Molecular Weight: 518.613
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2,3-dimethyl-4-quinolinyl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate(CAS DataBase Reference)
NIST Chemistry Reference: tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2,3-dimethyl-4-quinolinyl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate(503170-91-0)
EPA Substance Registry System: tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2,3-dimethyl-4-quinolinyl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate(503170-91-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 503170-91-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

503170-91-0 Suppliers

Recommended suppliers

503170-91-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 503170-91-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,1,7 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 503170-91:
(8*5)+(7*0)+(6*3)+(5*1)+(4*7)+(3*0)+(2*9)+(1*1)=110
110 % 10 = 0
So 503170-91-0 is a valid CAS Registry Number.

503170-91-0Upstream product

503170-91-0Downstream Products

503170-91-0Relevant academic research and scientific papers

Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)

-

, (2008/06/13)

The present application describes novel cyclic hydroxamic acids of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NR1, and S(O)p, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-α converting enzyme (TACE), aggrecanase or a combination thereof, pharmaceutical compositions containing the same, and methods of using the same.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 503170-91-0